首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药联合胰激肽原酶治疗非增生性糖尿病视网膜病变
引用本文:徐兵,李显波,王鹏波,宫卫星,张京文.中药联合胰激肽原酶治疗非增生性糖尿病视网膜病变[J].中国中医药现代远程教育,2008,6(11).
作者姓名:徐兵  李显波  王鹏波  宫卫星  张京文
作者单位:山东省乳山市人民医院,264500
摘    要:目的观察中药至目明合剂联合胰激肽原酶对非增生性糖尿病视网膜病变(NPDR)患者视力、眼底的改善作用。方法将62例112只患眼随机分为治疗组32例58只眼、对照组30例54只眼,2组基础治疗方法相同,对照组给予胰激肽原酶治疗,治疗组用药同对照组,并加用中药至目明合剂,治疗2个疗程后观察患者视力、眼底及其血脂、血液流变学的改善情况。结果治疗后治疗组患者的视力、眼底及其血脂、血液流变学均有明显改善,对照组患者除血脂外亦有改善,两组间比较差异有显着性(P<0.01)。结论中药至目明合剂联合胰激肽原酶治疗NPDR疗效优于单纯西药治疗。

关 键 词:糖尿病并发症  非增生性糖尿病视网膜病变  至目明合剂  胰激肽原酶

CLINICAL OBSERVATION ON NONPROLIFERATING DIABETIC RETINOPATHY BY CHINESE DRUGS COMBINED KALLIKREIN
Xubing LiXianbo WangPengbo,at el.CLINICAL OBSERVATION ON NONPROLIFERATING DIABETIC RETINOPATHY BY CHINESE DRUGS COMBINED KALLIKREIN[J].Chinese Medicine Modern Distance Education of China,2008,6(11).
Authors:Xubing LiXianbo WangPengbo  at el
Institution:Xubing LiXianbo WangPengbo,at el (People`s Hospital of Rushan,Rushan,Sh,ong 264500)
Abstract:Objective To assess the effect on the eyesight and eyeground condition of the patients with nonproliferating diabetic retinopathy (NPDR) treated by Zhimuming decoction combined kallikrein. Methods 112 sick eyes of 62 patients with NPDR were randomly divided into two groups: treated group (58 sick eyes of 32 patients) and control group (54 sick eyes of 30 patients). The two groups were treated with the same basic therapy. The control group were treated with kallikrein; the treated group took the same medicin...
Keywords:Diabetes Mellitus Complications  Nonproliferating Diabetic Retinopathy  Zhimuming Decoction  Kallikrein  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号